3.69 USD
-0.2 (-5.14%)
3.7002 USD
+0.01 (+0.28%)
ChartMill assigns a Buy % Consensus number of 79% to ESPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.59. This target is 78.71% above the current price.
ESPR was analyzed by 14 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about ESPR.
In the previous month the buy percentage consensus was at a similar level.
ESPR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-25 | Piper Sandler | Initiate | Overweight |
| 2025-09-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-04-25 | Needham | Reiterate | Buy -> Buy |
| 2025-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-05 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-11 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | Goldman Sachs | Reiterate | Neutral |
| 2024-12-17 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-12-13 | Needham | Reiterate | Buy -> Buy |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Needham | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
ESPERION THERAPEUTICS INC / ESPR FAQ
What is the average price target for ESPERION THERAPEUTICS INC (ESPR) stock?
14 analysts have analysed ESPR and the average price target is 6.59 USD. This implies a price increase of 78.71% is expected in the next year compared to the current price of 3.69.
What is the consensus rating for ESPERION THERAPEUTICS INC (ESPR) stock?
The consensus rating for ESPERION THERAPEUTICS INC (ESPR) is 78.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ESPR stock?
The number of analysts covering ESPERION THERAPEUTICS INC (ESPR) is 14.